Lawsuit Filed Over Gene Patent

Main Category: Litigation / Medical Malpractice
Also Included In: Women's Health / Gynecology;  Cancer / Oncology;  Genetics
Article Date: 15 May 2009 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:3 stars

3 (2 votes)

Healthcare Prof:not yet rated


A group of cancer patients, genetic researchers and professional pathologist organizations has filed a lawsuit against Myriad Genetics and the U.S. Patent Office over the patent of two genes associated with an increased risk of breast and ovarian cancers, the New York Times reports. According to the Times, the government more than 10 years ago granted Myriad the patent on the BRCA1 and BRCA2 genes, as well as the company's genetic test that measures a patient's risk for the cancers.

The lawsuit was filed by the American Civil Liberties Union and is believed to be the first of its kind, the Times reports. The lawsuit challenges the decision to grant patents on genes to Myriad and companies like it. The plaintiffs say that patents on genes restrict medical and research efforts, while companies like Myriad have said that the patent system supports innovation by giving them a temporary monopoly after they make a discovery, thereby rewarding prior investment in research and development.

Wendy Chung, the director of clinical genetics at Columbia University and a plaintiff in the case, said, "With a sole provider, there's mediocrity." The plaintiffs say that BRCA testing would improve with market competition. Furthermore, some plaintiffs argue that certain natural materials cannot be patented. Jan Nowak, president of the Association for Molecular Pathology and a plaintiff in the case, said, "You can't patent my DNA, any more than you can patent my right arm, or patent my blood."

To date, two government panels, including the National Research Council, found no evidence that gene patents result in significant impediments to research or medical care (Schwartz, New York Times, 5/13).

Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.

© 2009 The Advisory Board Company. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our litigation / medical malpractice section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
National Partnership for Women & Families. "Lawsuit Filed Over Gene Patent." Medical News Today. MediLexicon, Intl., 15 May. 2009. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/150156.php>

APA
National Partnership for Women & Families. (2009, May 15). "Lawsuit Filed Over Gene Patent." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/150156.php.

Please note: If no author information is provided, the source is cited instead.


Litigation / Medical Malpractice

Most Popular Articles



Follow Our Litigation News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Litigation / Medical Malpractice Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »